|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/16 | |||
| A61K 31/7088 | |||
| A61P 17/00 |
| (11) | Patento numeris | 2475388 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10815921.1 |
| Europos patento paraiškos padavimo data | 2010-09-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/047461 |
| Data | 2010-09-01 |
| (87) | Numeris | WO 2011/031600 |
| Data | 2011-03-17 |
| (30) | Numeris | Data | Šalis |
| 241324 P | 2009-09-10 | US |
| (72) |
RANKIN, Andrew, L., US
PFLANZ, Stefan, US
MUMM, John, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | USE OF IL-33 ANTAGONISTS TO TREAT FIBROTIC DISEASE |
| USE OF IL-33 ANTAGONISTS TO TREAT FIBROTIC DISEASE |